BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33347954)

  • 1. Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3.
    Massah S; Foo J; Li N; Truong S; Nouri M; Xie L; Prins GS; Buttyan R
    Mol Cell Endocrinol; 2021 Feb; 522():111136. PubMed ID: 33347954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.
    Li N; Truong S; Nouri M; Moore J; Al Nakouzi N; Lubik AA; Buttyan R
    Oncogene; 2018 Apr; 37(17):2313-2325. PubMed ID: 29429990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
    Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
    Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
    Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
    Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteomic approach identifies SAFB-like transcription modulator (SLTM) as a bidirectional regulator of GLI family zinc finger transcription factors.
    Zhang Z; Zhan X; Kim B; Wu J
    J Biol Chem; 2019 Apr; 294(14):5549-5561. PubMed ID: 30782847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ detection of estrogen receptor dimers in breast carcinoma cells in archival materials using proximity ligation assay (PLA).
    Iwabuchi E; Miki Y; Ono K; Onodera Y; Suzuki T; Hirakawa H; Ishida T; Ohuchi N; Sasano H
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):159-169. PubMed ID: 27264933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha.
    Zhang Y; Cheng JC; Huang HF; Leung PC
    Biochem Biophys Res Commun; 2013 Nov; 440(4):652-7. PubMed ID: 24099775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei.
    Ambrosino C; Tarallo R; Bamundo A; Cuomo D; Franci G; Nassa G; Paris O; Ravo M; Giovane A; Zambrano N; Lepikhova T; Jänne OA; Baumann M; Nyman TA; Cicatiello L; Weisz A
    Mol Cell Proteomics; 2010 Jun; 9(6):1352-67. PubMed ID: 20308691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
    Fan M; Bigsby RM; Nephew KP
    Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
    Drew BG; Hamidi H; Zhou Z; Villanueva CJ; Krum SA; Calkin AC; Parks BW; Ribas V; Kalajian NY; Phun J; Daraei P; Christofk HR; Hewitt SC; Korach KS; Tontonoz P; Lusis AJ; Slamon DJ; Hurvitz SA; Hevener AL
    J Biol Chem; 2015 Feb; 290(9):5566-81. PubMed ID: 25468909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
    Sui M; Jiang D; Hinsch C; Fan W
    Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.
    Kalet BT; Anglin SR; Handschy A; O'Donoghue LE; Halsey C; Chubb L; Korch C; Duval DL
    PLoS One; 2013; 8(7):e68815. PubMed ID: 23874775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
    Stoica A; Pentecost E; Martin MB
    Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
    Tonetti DA; Rubenstein R; DeLeon M; Zhao H; Pappas SG; Bentrem DJ; Chen B; Constantinou A; Craig Jordan V
    J Steroid Biochem Mol Biol; 2003 Oct; 87(1):47-55. PubMed ID: 14630090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.
    Platet N; Cunat S; Chalbos D; Rochefort H; Garcia M
    Mol Endocrinol; 2000 Jul; 14(7):999-1009. PubMed ID: 10894150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.